J&J vaccine under EU review over blood clots, AstraZeneca probe grows

Europe's drug regulator said on Friday that it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson's Covid-19 vaccine.

The European Medicines Agency's safety committee has also been looking at how AstraZeneca's Covid-19 vaccine is associated with very rare cases of unusual blood clots and said it was now reviewing reports of capillary leak syndrome in people given AstraZeneca's vaccine.